Tag
Weight Loss Drugs
3 articles
Viking's Oral VK2735 Hits a Tolerability Wall; Injectable Offers the Real Upside
VKTX's oral weight-loss candidate shows efficacy but high discontinuation rates in Phase 2 trials. The injectable formulation is where the value lies heading into 2027 Phase 3 readout.
Eli Lilly's Retatrutide FDA Bid Targets $25B Peak Sales in $100B Obesity Market
Lilly's triple-receptor weight-loss drug retatrutide heads to FDA with a 24 percent efficacy edge over rivals and a $1,200 price target from JPMorgan.
Galderma CEO: 'Ozempic Face' Is Driving Real Filler Demand
Galderma's injectables business is gaining a new patient demographic as GLP-1 users seek treatments for facial volume loss.